Economic costs of tobacco-related diseases in Hong Kong in 2021.

IF 4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Carmen S Ng, Coco Wing Sze Yu, Lancelot Leung, Eponine Kate Wong, Sai Yin Ho, Dennis K M Ip, Yongda Wu, Man Ping Wang, Jianchao Quan
{"title":"Economic costs of tobacco-related diseases in Hong Kong in 2021.","authors":"Carmen S Ng, Coco Wing Sze Yu, Lancelot Leung, Eponine Kate Wong, Sai Yin Ho, Dennis K M Ip, Yongda Wu, Man Ping Wang, Jianchao Quan","doi":"10.1136/tc-2024-058817","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hong Kong has one of the lowest smoking prevalence both within China and among high-income economies. As tobacco use consistently declined over the past decades, we examine whether there are corresponding cost reductions.</p><p><strong>Methods: </strong>Data were sourced from diverse population-wide datasets including government reports and public hospital records. Costs were calculated using Global Burden of Disease (GBD) 2019 risk estimates for active smoking. Direct costs encompassed public and private healthcare expenses, while indirect costs included the value of years of productive life lost, days off work due to active smoking or secondhand smoke exposure, and long-term care costs.</p><p><strong>Findings: </strong>Active smoking accounted for 26.3% of deaths in people aged 35 or over. Healthcare costs amounted to US$342 million and US$45 million for active and secondhand smoking. Annual tobacco-related diseases reached US$1.27 billion (0.3% of 2021 Hong Kong GDP). Compared with previous methods, the analysis using GBD 2019 risk estimates showed a twofold increase in lives lost due to active smoking but a 31.0% decrease for secondhand smoking.</p><p><strong>Interpretation: </strong>Past studies greatly underestimate the health burden of tobacco compared with more recent data on the wider risks. Despite a decline in smoking prevalence, the total costs associated with smoking have risen as utilisation shifts from primary care towards more expensive specialist care. The long-term health and economic impacts of tobacco use remain substantial even in regions of China that have now achieved low smoking prevalence.</p>","PeriodicalId":23145,"journal":{"name":"Tobacco Control","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/tc-2024-058817","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hong Kong has one of the lowest smoking prevalence both within China and among high-income economies. As tobacco use consistently declined over the past decades, we examine whether there are corresponding cost reductions.

Methods: Data were sourced from diverse population-wide datasets including government reports and public hospital records. Costs were calculated using Global Burden of Disease (GBD) 2019 risk estimates for active smoking. Direct costs encompassed public and private healthcare expenses, while indirect costs included the value of years of productive life lost, days off work due to active smoking or secondhand smoke exposure, and long-term care costs.

Findings: Active smoking accounted for 26.3% of deaths in people aged 35 or over. Healthcare costs amounted to US$342 million and US$45 million for active and secondhand smoking. Annual tobacco-related diseases reached US$1.27 billion (0.3% of 2021 Hong Kong GDP). Compared with previous methods, the analysis using GBD 2019 risk estimates showed a twofold increase in lives lost due to active smoking but a 31.0% decrease for secondhand smoking.

Interpretation: Past studies greatly underestimate the health burden of tobacco compared with more recent data on the wider risks. Despite a decline in smoking prevalence, the total costs associated with smoking have risen as utilisation shifts from primary care towards more expensive specialist care. The long-term health and economic impacts of tobacco use remain substantial even in regions of China that have now achieved low smoking prevalence.

二零一二年香港与烟草有关的疾病的经济成本。
背景:香港是中国及高收入经济体系中吸烟率最低的地区之一。由于烟草使用在过去几十年中持续下降,我们研究了是否有相应的成本降低。方法:数据来源于不同的人口数据集,包括政府报告和公立医院记录。成本是根据2019年全球疾病负担(GBD)对主动吸烟的风险估计来计算的。直接成本包括公共和私人医疗保健费用,而间接成本包括因主动吸烟或接触二手烟而损失的生产寿命年数的价值、因吸烟或接触二手烟而失去工作的天数以及长期护理成本。研究结果:在35岁及以上的人群中,吸烟占死亡人数的26.3%。主动吸烟和二手吸烟的医疗费用分别为3.42亿美元和4500万美元。每年与烟草有关的疾病达12.7亿美元(占2021年香港本地生产总值的0.3%)。与以前的方法相比,使用GBD 2019风险估计进行的分析显示,主动吸烟导致的死亡人数增加了两倍,但二手烟的死亡人数减少了31.0%。解释:与有关更广泛风险的最新数据相比,过去的研究大大低估了烟草的健康负担。尽管吸烟率有所下降,但随着利用从初级保健转向更昂贵的专科保健,与吸烟有关的总成本有所上升。即使在中国目前已实现低吸烟率的地区,烟草使用的长期健康和经济影响仍然很大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tobacco Control
Tobacco Control 医学-公共卫生、环境卫生与职业卫生
CiteScore
9.10
自引率
26.90%
发文量
223
审稿时长
6-12 weeks
期刊介绍: Tobacco Control is an international peer-reviewed journal covering the nature and consequences of tobacco use worldwide; tobacco''s effects on population health, the economy, the environment, and society; efforts to prevent and control the global tobacco epidemic through population-level education and policy changes; the ethical dimensions of tobacco control policies; and the activities of the tobacco industry and its allies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信